Concepedia

Eriko Murakami

EM

Statistics

Publications

5

Citations

532

H-Index

5

Active since

2014

Affiliations

Wakayama Medical University(Current)

Eriko Murakami is an author at Wakayama Medical University specializing in oncology, immunology, and cancer immunotherapy.

ORCID

Publications per year

2014–2020

5

Publications

5

Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab

Koichi Sato, Hiroaki Akamatsu, Eriko Murakami et al. · Lung Cancer · 2017 · 378 citations · Full text

, , +14

Immune-Related Adverse Events by Immune Checkpoint Inhibitors Significantly Predict Durable Efficacy Even in Responders with Advanced Non-Small Cell Lung Cancer

Hiroaki Akamatsu, Eriko Murakami, Jun Oyanagi et al. · The Oncologist · 2019 · 79 citations · Full text

, , +17

Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab

Koichi Sato, Hiroaki Akamatsu, Eriko Murakami et al. · Annals of Oncology · 2017 · 48 citations · Full text

, , +14

CD24, not CD47, negatively impacts upon response to PD‐1/L1 inhibitors in non–small‐cell lung cancer with PD‐L1 tumor proportion score < 50

Yuichi Ozawa, Yuhei Harutani, Jun Oyanagi et al. · Cancer Science · 2020 · 16 citations · Full text

, , +17

Altered intracellular region of <scp>MUC</scp>1 and disrupted correlation of polarity‐related molecules in breast cancer subtypes

Misato Iizuka, Yoko Nakanishi, Fumi Fuchinoue et al. · Cancer Science · 2014 · 11 citations · Full text

, , +17

1–5 of 5